Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2010 Oct;54(10):4526. doi: 10.1128/AAC.01137-10

New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparumin Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine

S Krudsood 1, S Looareesuwan 1, N Tangpukdee 1, P Wilairatana 1, W Phumratanaprapin 1, W Leowattana 1, K Chalermrut 1, S Ramanathan 1, V Navaratnam 1, P Olliaro 1, M Vaillant 1, J R Kiechel 1, W R J Taylor 1
PMCID: PMC2944600

Volume 54, no. 9, p. 3730-3737, 2010. Page 3732, column 1, line 32: “Giemsa-stained thick and thin blood films were examined at baseline; every 6 hours for the first 3 days; and on day 7, day 14, day 21, and day 28” should read “Giemsa-stained thick and thin blood films were examined at baseline, every 12 hours until two consecutive slides were negative, thereafter daily through day 7, and then on days 14, 21, and 28.”

Page 3736, column 1, line 50: “similar to those of Bethell et al. and Price et al. (3.7 and 3, respectively) (7, 24)” should read “similar to those of Price et al. (3.7 and 3, respectively) (24).”


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES